How do cells and tissues in the body respond to the environment? How do
they communicate with each other and know their
role in the body? Many of the answers lie in biosignaling: the proteins, small molecules and many intricate pathways that make up our cellular communication networks and response teams. One important biosignaling pathway is the kinase cascade. The pathways Protein Kinase B is involved in tend to be kinase cascades. |
|||
What is a kinase? Kinases are proteins that add phosphate groups to target proteins, either activating or inactivating them to cause a cellular response. |
Figure 1. Kinases add phosphate groups to proteins to alter their function, while phosphatases remove phosphate groups. |
||
Figure 2. An example of a protein kinase cascade. The growth factor binds to its receptor and activates the phosphorylation of RAS, which then phosphorylates and activates Raf, which can then phosphorylate MEK and activate it, etc etc. |
Frequently, activation of a kinase leads to a protein kinase cascade,
resulting in the rapid amplification of extra-cellular signals. Protein Kinase B participates in many different signaling cascades, some of which are involved in cell growth and death.
|
| Nicotine and Smoking | |||||
What is nicotine and how does it react in the human body? |
Figure 3. The biosynthesis of nicotine in tobacco plants begins with the amino acid ornithine, which is then converted, through multiple enzymatic steps, to nicotine. |
||||
|
|||||
Nicotinic acetylcholine receptors normally bind the neurotransmitter acetylcholine. Structurally, the receptors are made up of multiple subunits (a1-a10 , b1-b4), which come together to form an ion channel. When the ligand (like acetylcholine) binds the receptor, the channel opens and ions flow through causing the transmission of neuronal singals. Ligand specificity is determined by the composition of the channel. Channels can be heteromeric, containing different subunits, or be homomeric, containing multiple copies of one type of subunit (West, K. A., et al. 2003).
|
Figure 5. Examples of nAchRs. |
||||
Carcinogenic components of cigarette smoke
|
|
NNK, a carcinogenic metabolite of Nicotine
Figure 6. Nicotine is metabolized to NNK through multiple steps. NNK is a very toxic carcinogen and is known to cause lung cancer. |
An important carcinogenic metabolite of nicotine is 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Once nicotine is introduced into the body it is metabolized to NNK by enzymes in the body. Nicotine is first converted
to 2'-hydroxynicotine, then to 4-(methylamino)-1-(3-pyridyl)-1-butanone,
and finally to NNK (Hecht,
S. A. et al. 2000). NNK is known to cause lung
cancer no matter how nicotine is introduced into the body (West,
K. A., et al. 2003). Smoking has been linked heavily to many diseases, especially emphysema and lung cancer.
|
Cancer is the name given to cells that have broken the boundaries of normal cell proliferation and location. In order for a cell to become cancerous, it must first be able to divide without regulation, and then move to a new location and continue to survive. Cancers develop slowly and require multiple genetic mutations in key genes responsible for controlling cell division and cell behavior.
Preventing Cancer
|
Figure 7. In this example, a cell of the epithelium obtains a mutation that causes it to divide without control; it then obtains a second mutation that causes it to divide and grow even more; finally a third mutation causes the cell to break its normal location boundaries and invade the surrounding tissues. If the cells invade the blood stream, they can travel to new parts of the body and begin growing there. This is now known as metastatic cancer. |
In summary: What can cause/promote cancer: 1. DNA damage 2. increased cell proliferation (inhibition of cell cycle checkpoints) 3. inhibition of cell death mechanisms 4. break of normal cell boundaries (invasion into other tissues) |
| Previous |